Clinical Trial Update: Cat-PAD Exposure Chamber Study [Phase 2]

View source ↗

Summary

Phase 2 exposure chamber study of Cat-PAD for cat allergy by Circassia Limited has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cat Allergy

Drugs mentioned

• Cat-PAD

Snippet

Sponsor: Circassia Limited | Conditions: Cat Allergy | Phase 2 | Status: COMPLETED